SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-22-020663
Filing Date
2022-05-18
Accepted
2022-05-18 17:07:20
Documents
12
Period of Report
2022-05-18
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K mtcr-8k_20220518.htm   iXBRL 8-K 57955
  Complete submission text file 0001564590-22-020663.txt   190445

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA mtcr-20220518.xsd EX-101.SCH 5593
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE mtcr-20220518_lab.xml EX-101.LAB 20063
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mtcr-20220518_pre.xml EX-101.PRE 11937
6 EXTRACTED XBRL INSTANCE DOCUMENT mtcr-8k_20220518_htm.xml XML 3674
Mailing Address 4225 EXECUTIVE SQUARE SUITE 600 SAN DIEGO CA 92037
Business Address 4225 EXECUTIVE SQUARE SUITE 600 SAN DIEGO CA 92037 858-369-7800
Metacrine, Inc. (Filer) CIK: 0001634379 (see all company filings)

IRS No.: 472297384 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39512 | Film No.: 22940073
SIC: 2834 Pharmaceutical Preparations